Development of novel indole–quinoline hybrid molecules targeting bacterial proton motive force
Journal of Applied Microbiology · 01.05.2024 · 135 (5)
DOI: 10.1093/jambio/lxae104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, online erschienen am 27.04.2024. Verfasst von Jinbeom Seo und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Microbial Sensitivity Tests, Quinolines, Proton-Motive Force. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Aims
This study aimed to develop an editable structural scaffold for improving drug development, including pharmacokinetics and pharmacodynamics of antibiotics by using synthetic compounds derived from a (hetero)aryl-quinoline hybrid scaffold. Methods and results In this study, 18 CF3-substituted (hetero)aryl-quinoline hybrid molecules were examined for their potential antibacterial activity against Staphylococcus aureus by determining minimal inhibitory concentrations. These 18 synthetic compounds represent modifications to key regions of the quinoline N-oxide scaffold, enabling us to conduct a structure-activity relationship analysis for antibacterial potency. Among the compounds, 3 m exhibited potency against with both methicillin resistant S. aureus strains, as well as other Gram-positive bacteria, including Enterococcus faecalis and Bacillus subtilis. We demonstrated that 3 m disrupted the bacterial proton motive force (PMF) through monitoring the PMF and conducting the molecular dynamics simulations. Furthermore, we show that this mechanism of action, disrupting PMF, is challenging for S. aureus to overcome. We also validated this PMF inhibition mechanism of 3 m in an Acinetobacter baumannii strain with weaken lipopolysaccharides. Additionally, in Gram-negative bacteria, we demonstrated that 3 m exhibited a synergistic effect with colistin that disrupts the outer membrane of Gram-negative bacteria.
Conclusions
Our approach to developing editable synthetic novel antibacterials underscores the utility of CF3-substituted (hetero)aryl-quinoline scaffold for designing compounds targeting the bacterial proton motive force, and for further drug development, including pharmacokinetics and pharmacodynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Seo, J., Kim, J. H., Ko, N., Kim, J., Moon, K., Kim, I. S., & Lee, W. (2024). Development of novel indole–quinoline hybrid molecules targeting bacterial proton motive force. Journal of Applied Microbiology, 135(5). https://doi.org/10.1093/jambio/lxae104
Vancouver
Seo J, Kim JH, Ko N, Kim J, Moon K, Kim IS, et al. Development of novel indole–quinoline hybrid molecules targeting bacterial proton motive force. Journal of Applied Microbiology. 2024;135(5). doi:10.1093/jambio/lxae104
BibTeX
@article{Seo2024,
author = {Seo, Jinbeom and Kim, Ji-Hoon and Ko, Nayoung and Kim, Jihyeon and Moon, Kyeongwon and Kim, In Su and Lee, Wonsik},
title = {Development of novel indole–quinoline hybrid molecules targeting bacterial proton motive force},
journal = {Journal of Applied Microbiology},
year = {2024},
volume = {135},
number = {5},
doi = {10.1093/jambio/lxae104}
}
EUVIMED